SureTrader SPDR Advertisement
Home > Boards > US OTC > Biotechs >

PharmaRoth Labs, Inc. (ROTH)

ROTH RSS Feed
Add ROTH Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator sunspotter, sweetlou
Search This Board:
Last Post: 8/30/2015 2:25:05 AM - Followers: 66 - Board type: Free - Posts Today: 2

FROI now retitled PharmaRoth Labs. New name.New Ticker: ROTH. And it's a non-SEC filing dark Pinky stinky.

Same old pump and dump scam, though.
Dark, dark, dark:

 

"FROI Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 000-53337

FERO INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

c/o Kane Kessler, P.C.
1350 Avenue of the Americas, New York, NY 10019
(212) 541-6222
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) [ ]

Rule 12g-4(a)(2) [X]

Rule 12h-3(b)(1)(i) [ ]

Rule 12h-3(b)(1)(ii) [X]

Rule 15d-6 [ ]

Approximate number of holders of record as of the certification or notice date: 12

Pursuant to the requirements of the Securities Exchange Act of 1934, Fero Industries, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
FERO INDUSTRIES, INC.

Date: December 31, 2012 By: Luis Manuel Ornelas Lopez
Name: Luis Manuel Ornelas Lopez
Title: President and Chief Executive Officer

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature."

 

REAL DUE DILLIGENCE BELOW
 
 
 

 

Investor Information

Press Releases

Resources

Legal Disclaimer

INVESTOR INFORMATION

 

PHARMAROTH LABS, INC. (OTC: ROTH)

PharmaRoth Labs Inc. (OTC: ROTH) is focused on diabetes prevention and treatments. The Company holds the intellectual property and other exclusive world-wide rights related to the production, marketing, and distribution of Sucanon®, a oral treatment for Type II diabetes.

RECENT NEWS

July 23, 2014
PharmaRoth Labs, Inc. Announces New Distribution Agreement in China

April 16, 2014
PharmaRoth Labs, Inc. Announces Mexican Distributor Surpasses Sales Goal

March 24, 2014
PharmaRoth Labs, Inc. Announces Retails and Wholesale Distribution Channels in Mexico

March 17, 2014
PharmaRoth Labs, Inc. Announces Results From FDA Application

STOCK INFORMATION
OTC: ROTH

 

CONTACTS

Stock Transfer Agent:
Pacific Stock Transfer
4045 S. Spencer Street
Suite 403
Las Vegas, NV 89119
702-361-3033
www.pacificstocktransfer.com

Investor Relations:
IR@PharmaRoth.com
 
 
 

 

What is Sucanon®?

Clinical Trial Summary

Clinical Results

Regulatory Approvals

 

Sucanon®...Diabetes is not curable but is treatable...enjoy life

 

What is Sucanon®?:
Sucanon® is one of only several drugs approved in the world, belonging to a class of diabetic medications called insulin sensitizers.  Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver’s sensitivity to insulin.  Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars.

 

 
1. Insulin binding to receptors and entering the cell, (which is impeded in NIDDM patients), is essential for the uptake of glucose 2. Sucanon® increases the binding of insulin to its receptors 3. Sucanon® increases the internalization of insulin 4. As a result, Sucanon® increases the intracellular level of insulin, which then increases the uptake of glucose.

 

 

Sucanon®  is a medication that helps the body make better use of its own insulin, the hormone that controls blood sugar levels.  Type II Diabetics produce insulin, but their cells gradually lose the ability to absorb and use insulin, to get sugar out of the blood stream.  Sucanon®  transports sugar out of the blood stream and into cells where it can be burned.  Sucanon®  particularly helps muscle cells use insulin and thus draw sugar out of the blood stream.


Sucanon® increases sensitivity to insulin which leads to decreased blood sugar levels and a reduction of a wide range of Type II Diabetes symptoms,  including: weight gain, fatigue, excess thirst and excess urination.  The reduction in blood sugar levels also reduces the possibility of peripheral nerve damage; the damage caused to peripheral nerves by chronic high blood sugar can ultimately lead to impotence in men and amputation of limbs in both men and women.

 
Company Updated Profile
Contact Info
8250 W. Charleston Blvd
Suite 110
Las Vegas, NV 89117

 
Website: http://www.pharmaroth.com
Phone: 702-544-0195
Email:
info@pharmaroth.com
Business Description
PharmaRoth Labs, Inc. is focused on diabetes prevention and treatments. The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon(R), an oral treatment for Type-II diabetes. Sucanon(R) is a member of a class of diabetic medications called insulin sensitizers. Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin. Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars. PharmaRoth's strategy is to increase awareness, acceptance, and distribution of Sucanon(R) globally.
ROTH Security Details
Share Structure
  Market Value1 $1,238,958 a/o Apr 27, 2015
  Authorized Shares 500,000,000 a/o Oct 01, 2014
  Outstanding Shares 317,681,637 a/o Mar 12, 2015
  -Restricted Not Available  
  -Unrestricted Not Available  
  Held at DTC Not Available  
  Float 124,850,000 a/o Jan 22, 2014
  Par Value 0.001  
Transfer Agent(s)
Pacific Stock Transfer Co.
Shareholders
Shareholders of Record 1,019 a/o Jan 22, 2014
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ROTH
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#1893  Sticky Note "the information you provided is absolutely wrong." sunspotter 03/21/13 11:27:29 AM
#3650   This just in... DPP-4 inhibitors may cause severe sweetlou 08/30/15 02:25:05 AM
#3649   May-June 2007 issue of Diabetes Hoy (publication of sweetlou 08/30/15 01:08:06 AM
#3648   Let's try again to clarify the whole side sweetlou 08/29/15 11:58:58 PM
#3647   The "shady language" you identified and called a sweetlou 08/29/15 11:07:50 PM
#3646   What verification would satisfy you? old biohf guy 08/29/15 01:30:12 PM
#3645   Could you post your results ....and have them Jayyy 08/28/15 03:30:14 PM
#3644   It worked great for me, so now its old biohf guy 08/28/15 11:14:28 AM
#3643   I wouldn't put Sucanon in my body--but let Jayyy 08/28/15 11:06:16 AM
#3642   Jayyy, buy some Sucanon and do your own old biohf guy 08/28/15 09:59:45 AM
#3641   I challenge you to show one INDEPENDENT study Jayyy 08/28/15 09:41:53 AM
#3639   Jayyy, lets try another way. Many Sucanon old biohf guy 08/27/15 11:02:37 AM
#3638   Last time on this my friend. If Jayyy 08/27/15 09:34:43 AM
#3637   Jayyy, again you are dodging the question. old biohf guy 08/27/15 09:22:03 AM
#3636   Jayyy, when the application was submitted to the old biohf guy 08/27/15 07:39:43 AM
#3635   "It's important for the public to realize all Jayyy 08/26/15 05:46:47 PM
#3634   This has nothing to do with Sucanon being old biohf guy 08/26/15 03:52:58 PM
#3633   In 2013 ROTH submitted its NDI to FDA. Jayyy 08/26/15 03:17:37 PM
#3632   Jayyy, the FDA never said Sucanon was "non old biohf guy 08/26/15 01:56:27 PM
#3631   Jayyy, the FDA never used the words old biohf guy 08/26/15 01:49:49 PM
#3629   Jayyy, where is the evidence that Sucanon is old biohf guy 08/26/15 08:36:20 AM
#3628   Here is one bit of shady language which Jayyy 08/26/15 08:27:14 AM
#3627   Jayyy, I will spot you that I used sweetlou 08/26/15 12:04:49 AM
#3626   You are completely wrong on Zicam and the Jayyy 08/25/15 06:47:10 PM
#3624  Restored Statements that rely on scientific ignorance, of course, sweetlou 08/25/15 11:38:53 AM
#3622   sweetlou, thanks for all the balanced and informative old biohf guy 08/25/15 08:10:01 AM
#3621   "Real homeopathic medicines consist only of water, of course" sweetlou 08/24/15 09:37:01 PM
#3619   There is a "stench" here but not for Jayyy 08/24/15 08:56:53 AM
#3618   Do I smell a possible run here? leonardo66 08/24/15 08:35:56 AM
#3617   "As an example, Zicam, a homeopathic remedy containing sunspotter 08/24/15 03:54:06 AM
#3616   For those wanting a complete response to sunspotters sweetlou 08/23/15 08:29:35 PM
#3615   Actually, there are many in the scientific community sweetlou 08/23/15 07:56:34 PM
#3614   Thank you for reporting some of sunspotters previous sweetlou 08/23/15 07:41:53 PM
#3613   Yes it speaks to being a bought and Jayyy 08/23/15 07:40:57 PM
#3612   Dr Jiminez did a trial and based on sweetlou 08/23/15 06:09:12 PM
#3611   For those who cant keep up with the Jayyy 08/23/15 04:47:30 PM
#3610   Yep--Dr J was and is an insider--not independent Jayyy 08/23/15 04:46:06 PM
#3609   Information has indeed been posted on this subject sweetlou 08/23/15 01:55:05 PM
#3608   Difficult to keep up with the statements... sweetlou 08/22/15 06:53:59 AM
#3607   Several other trials were done on Sucanon. sweetlou 08/21/15 09:09:20 PM
#3606   Sales are posted on quarterly reports posted at sweetlou 08/21/15 07:16:37 PM
#3605   Show us the facts on sales--show us sales Jayyy 08/21/15 03:06:44 PM
#3604   Jayyy, I also emailed with Ana at the old biohf guy 08/21/15 09:32:46 AM
#3603   THIS WAS NOT an independent clinical trial. Jayyy 08/21/15 08:45:37 AM
#3602   Not true--nice try. I contacted them. Jayyy 08/21/15 08:33:51 AM
#3601   The Mexican Diabetes Association is likely much more sweetlou 08/20/15 10:03:29 PM
#3600   Regarding trials and efficacy: Study presented in sweetlou 08/20/15 09:55:56 PM
#3599   THIS COMPANY FITS NONE OF THE REQUIREMENTS you Jayyy 08/20/15 12:50:31 PM
#3598   sweetlou, I agree with your opinion that "Ultimately old biohf guy 08/20/15 08:59:31 AM
#3597   We also know that Sucanon works in decreasing sweetlou 08/19/15 10:39:00 PM
#3596   We all know that Roth is current with old biohf guy 08/19/15 06:37:13 PM
PostSubject